Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Keigo Hanada"'
Autor:
Nyambayar Dashtsoodol, Tomokuni Shigeura, Takuya Tashiro, Minako Aihara, Toshihiro Chikanishi, Hiromi Okada, Keigo Hanada, Hirokazu Sano, Akihiko Kurogi, Masaru Taniguchi
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Current tumor therapies, including immunotherapies, focus on passive eradication or at least reduction of the tumor mass. However, cancer patients quite often suffer from tumor relapse or metastasis after such treatments. To overcome these problems,
Externí odkaz:
https://doaj.org/article/8e34f806a406476795e2af42c4080e56
Autor:
Wentao Tang, Keigo Hanada, Yoshiharu Motoo, Hiroyuki Sakamaki, Takaaki Oda, Kazuyuki Furuta, Hikaru Abutani, Satoru Ito, Kiichiro Tsutani
Publikováno v:
Journal of Medical Economics. 26:614-626
Publikováno v:
Journal of Cosmetic Dermatology. 21
Publikováno v:
Journal of cosmetic dermatology. 21(7)
Few cosmetic ingredients are shown to be able to safely remove or lighten facial dark spots once they have formed. OG has been reported to possess oxidation power and exhibit various biological activities such as antibacterial, antiviral, and wound h
Autor:
Keigo Hanada, Tetsuaki Hirase, Hirotaka Watada, Tatsunori Murata, Daisuke Yabe, Tomoo Okamura, Fumiko Yamamoto, Hiroyuki Sakamaki
Publikováno v:
Diabetes Therapy
Introduction We evaluated the cost-effectiveness of linagliptin in Japan by estimating the lifetime outcome based on clinical event rates from the Asian subpopulation of the CARMELINA trial. In CARMELINA, linagliptin added to standard of care (SoC) v
Publikováno v:
The Journal of Dermatology
Psoriasis is a chronic autoimmune disease affecting skin which may also manifest in nails and joints. Several biologic treatments have been approved in Japan for psoriasis. Each biologic has a different profile for efficacy and safety, including diff
Autor:
Toshikazu Nakamura, Kazuhiro Fukuta, Kunio Matsumoto, Eri Adachi, Kiichi Adachi, Keigo Hanada, Daichika Hayata
Publikováno v:
Journal of Biotechnology. 133(4):478-485
金沢大学がん研究所附属分子標的がん医療研究開発センター
Hepatocyte growth factor (HGF) is biosynthesized as a biologically inactive, single-chain form (pro-HGF). Its activation is associated with cleavage at Arg494-Val4
Hepatocyte growth factor (HGF) is biosynthesized as a biologically inactive, single-chain form (pro-HGF). Its activation is associated with cleavage at Arg494-Val4
Autor:
Luis A. Solchaga, Arnold I. Caplan, Victor M. Goldberg, Thomas M. Hering, Keigo Hanada, Brian Johnstone, Jung U. Yoo
Publikováno v:
Journal of Cellular Biochemistry. 81:284-294
Periosteum contains osteochondral progenitor cells that can differentiate into osteoblasts and chondrocytes during normal bone growth and fracture healing. TGF-β1 and BMP-2 have been implicated in the regulation of the chondrogenic differentiation o
Autor:
Makoto Tamura, Takahide Kurokawa, Ikuo Aoyama, Kozo Nakamura, Keigo Hanada, Takao Awa, Hiroshi Kawaguchi, Yoshiyuki Hiyama
Publikováno v:
Journal of Orthopaedic Research. 15:307-313
The effect on intraosseous bone formation of a single local injection of recombinant human basic fibroblast growth factor into the distal femur was examined in normal and ovariectomized rabbits. In normal rabbits, basic fibroblast growth factor incre
Autor:
Noriko Yamamoto, Kiyonoshin Ichikawa, Kazuyuki Furuya, Keigo Hanada, Motonori Miyakawa, Seiji Amano, Hiroaki Nejishima, Nao Oguro, Yuji Sumita, Tsutomu Nakamura
Publikováno v:
Biologicalpharmaceutical bulletin. 26(11)
A novel nonsteroidal androgen receptor (AR) binder, S-40503, was successfully generated in order to develop selective androgen receptor modulators (SARMs). We evaluated the binding specificity for nuclear receptors (NRs) and osteoanabolic activities